Return to content in this issue

 

SARS-CoV-2 Infection among Patients with Mastocytosis: An EPICOVIDEHA Report

Criscuolo M1*, Salmanton-García J2*, Fracchiolla N3, Dragonetti G1, Khanna N4, Weinbergerová B5, Schönlein M6, Machado M7, Labrador J8, Kolditz M9, Itri F10, Gomes da Silva M11, Bonuomo V12, Sciumè M3, Nunes Rodrigues R11, Gräfe S13, Marchesi F14, Cornely OA15, Pagano L16

1Hematology Unit, Fondazione Policlinico Universitario Agostino Gemelli - IRCCS, Rome, Italy
2University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Excellence Center for Medical Mycology (ECMM), Cologne, Germany; University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany
3Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
4Division of Infectious Diseases and Hospital Epidemiology, and Department of Clinical Research, University and University Hospital of Basel, Basel, Switzerland
5University Hospital Brno - Department of Internal Medicine, Hematology and Oncology, Brno, Czech Republic
6Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
7Clinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain
8Department of Hematology, Hospital Universitario de Burgos, Burgos, Spain
9University Hospital Dresden, Dresden, Germany
10San Luigi Gonzaga Hospital - Orbassano, Orbassano, Italy
11Portuguese Institute of Oncology, Lisbon, Portugal
12Department of Medicine, Section of Hematology, University of Verona, Verona, Italy
13Universitätsklinikum Hamburg Eppendorf, Hamburg, Germany University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Excellence Center for Medical Mycology (ECMM), Cologne, Germany; University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany
14Hematology and Stem Cell Transplant Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy
15University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Excellence Center for Medical Mycology (ECMM), Cologne, Germany; University of Cologne, Faculty of Medicine and University Hospital Cologne, Chair Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany; University of Cologne, Faculty of Medicine and University Hospital Cologne, Clinical Trials Centre Cologne (ZKS Köln), Cologne, Germany; University of Cologne, Faculty of Medicine and University Hospital Cologne, Center for Molecular Medicine Cologne (CMMC), Cologne, Germany; German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany
16Hematology Unit, Fondazione Policlinico Universitario Agostino Gemelli - IRCCS, Rome, Italy; Hematology Unit, Università Cattolica del Sacro Cuore, Rome, Italy
*Equal contribution

J Investig Allergol Clin Immunol 2023; Vol. 33(2)
doi: 10.18176/jiaci.0845

Key words: Systemic mastocytosis, SARS-CoV-2